Genetic variability of the mTOR pathway and prostate cancer risk in the European Prospective Investigation on Cancer (EPIC)
The mTOR (mammalian target of rapamycin) signal transduction pathway integrates various signals, regulating ribosome biogenesis and protein synthesis as a function of available energy and amino acids, and assuring an appropriate coupling of cellular proliferation with increases in cell size. In addi...
Egile Nagusiak: | Campa, D, Hüsing, A, Stein, A, Dostal, L, Boeing, H, Pischon, T, Tjønneland, A, Roswall, N, Overvad, K, Østergaard, J, Rodríguez, L, Sala, N, Sánchez, M, Larrañaga, N, Huerta, J, Barricarte, A, Khaw, K, Wareham, N, Travis, R, Allen, N, Lagiou, P, Trichopoulou, A, Trichopoulos, D, Palli, D, Sieri, S, Tumino, R, Sacerdote, C, Van Kranen, H, Bueno-De-Mesquita, H, Hallmans, G, Johansson, M, Romieu, I, Jenab, M, Cox, D, Siddiq, A, Riboli, E, Canzian, F, Kaaks, R |
---|---|
Formatua: | Journal article |
Hizkuntza: | English |
Argitaratua: |
Public Library of Science
2011
|
Antzeko izenburuak
-
Genetic variability of the mTOR pathway and prostate cancer risk in the European Prospective Investigation on Cancer (EPIC).
nork: Daniele Campa, et al.
Argitaratua: (2011-02-01) -
Genetic variability of the forkhead box O3 and prostate cancer risk in the European Prospective Investigation on Cancer.
nork: Campa, D, et al.
Argitaratua: (2011) -
Insulin-like growth factor i and risk of breast cancer by age and hormone receptor status - A prospective study within the EPIC cohort
nork: Kaaks, R, et al.
Argitaratua: (2014) -
Insulin-like growth factor I and risk of breast cancer by age and hormone receptor status-A prospective study within the EPIC cohort.
nork: Kaaks, R, et al.
Argitaratua: (2014) -
Diabetes mellitus, insulin treatment, diabetes duration, and risk of biliary tract cancer and hepatocellular carcinoma in a European cohort.
nork: Schlesinger, S, et al.
Argitaratua: (2013)